Cf. Mccabe et al., DEVELOPMENTALLY-REGULATED NEURAL PROTEIN EAP-800 IS EXPRESSED BY MYOCARDIUM AND CARDIAC NEURAL CREST DURING CHICK EMBRYOGENESIS, Developmental dynamics, 203(1), 1995, pp. 51-60
The spatiotemporal distribution of EAP-300 (embryonic avian polypeptid
e of 300 kDa) was analyzed in embryonic chick heart using immunohistoc
hemistry and confocal microscopy. EAP-300 is a developmentally regulat
ed protein initially characterized in neural cells from chick retina.
Myocardial cells all along the early tubular heart were ubiquitously i
mmunolabeled for EAP-300 by embryonic day 2 (E2, Stage 13)). At E5 (St
age 24), myocardial EAP-300 expression levels remained significant in
both atrial and ventricular myocardium. At E6 (Stage 28), distinct pop
ulations of EAP-300 immunolabeled cells were also observed external to
the heart, in septal mesenchymal tissue and neural ganglia adjacent t
o the outflow tract; these cell populations were confirmed as neural c
rest-derived by co-localization of EAP-300 and HNK-1. At E13 (Stage 39
), myocardial immunolabeling for EAP-300 was no longer ubiquitous, but
increasingly restricted to conduction tissues, including the atrioven
tricular bundle and subendocardial Purkinje cells. This restriction of
immunolabeling could be demonstrated definitively at E15 (stage 41),
by which stage subendocardial and periarterial Purkinje fibers were cl
early immunoreactive for EAP-300 and several known markers of chick co
nduction tissue, including specific myosin heavy chain isoforms and co
nnexin42, a gap junctional protein preferentially expressed by Purkinj
e fibers. Just prior to hatching at E21 (Stage 46), immunolabeling of
conduction tissues was reduced, although still above that of non-condu
ctile myocardium. This spatiotemporal map of cardiac EAP-300 expressio
n indicates that it is independently and transiently expressed in earl
y myocardium, cardiac conduction tissue, and neural crest derivatives
during development. (C) 1995 Wiley-Liss, Inc.